Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 109
Selected: 0
NCT IDTitle
NCT03290950A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma
NCT00177164Risperdal Consta for Bipolar Disorder
NCT01701063An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus
NCT04775550DARA RVD For High Risk SMM
NCT03939182Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma
NCT00855413HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
NCT02422797Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)
NCT06066346A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
NCT05896748Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study
NCT01241760VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection
NCT02838693Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes)
NCT04394936An Explorative Psoriasis Biomarker Study
NCT02002130The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes
NCT06083922A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
NCT02841033Daratumumab for the Treatment of Patients With AL Amyloidosis
NCT03503344Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer
NCT03093272A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer
NCT03475628Effects of Daratumumab Monotherapy on Bone Parameters in Patients With Relapsed and /or Refractory Multiple Myeloma
NCT06107738Iberdomide and Daratumumab As Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
NCT06816992ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC
NCT00214552Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.
NCT02955810Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA)
NCT03899155Pan Tumor Rollover Study
NCT03404635Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism
NCT05523089The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults
NCT00578240Molecular Studies and Clinical Correlations in Human Prostatic Disease
NCT04399551A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries
NCT05629052TrEatment Approach in the Multimodal Era Registry
NCT00222807Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus
NCT02478632Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen
NCT03993847CLassification of Axial SpondyloarthritiS Inception Cohort
NCT01376401Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma
NCT03696160The Late Presenter Treatment Optimisation Study
NCT02929745Single Cell Genomics of Psoriatic Skin
NCT03450057Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment
NCT05285137Study of CD388 Intramuscular or Subcutaneous Administration in Healthy Subjects
NCT02471196Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease
NCT03655223Early Check: Expanded Screening in Newborns
NCT00167154Risperidone and Suicidality in Major Depressive Disorder
NCT00006371A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer
NCT04268498A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma
NCT02951052Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults
NCT02438631Placental Passage and Disposition of Drugs: A Physiology-based Approach
NCT05826756Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting
NCT02756247A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma
NCT04116606Antidepressant Trial With P2X7 Antagonist JNJ-54175446
NCT03541174A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety
NCT02938520Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants
NCT05546242Improving HIV-1 Control in Africa with Long Acting Antiretrovirals
NCT01848028PsoBest - The German Psoriasis Registry